IBRX IMMUNITYBIO INC

Ownership history in TWO SIGMA SECURITIES, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA SECURITIES, LLC reported a position in IMMUNITYBIO INC (IBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.0%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 22,860 +10,538 +85.5% 0.01% $56K $2.46
2025 Q2 REDUCED 12,322 -31,282 -71.7% 0.00% $33K $2.64
2023 Q4 ADDED 43,604 +9,624 +28.3% 0.00% $219K $5.02
2023 Q3 ADDED 33,980 +22,302 +191.0% 0.00% $57K $1.69
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IBRX price (monthly, adj. close)
← Back to TWO SIGMA SECURITIES, LLC Holdings